Ren Zhipeng, Hou Xiaobin, Xue Zhiqiang, Zhang Lianbin, Wang Bo, Wen Jiaxin, Chu Xiangyang
Department of Thoracic Surgery, First Medical Center, General Hospital of Chinese PLA, Beijing, China.
J Gastrointest Oncol. 2021 Aug;12(4):1265-1276. doi: 10.21037/jgo-21-409.
Esophageal cancer (EC) is one of the most common malignancies worldwide, with high morbidity and mortality rates. Circulating tumor cell (CTC) detection has become a novel approach in clinical study of EC. In this study, the relationship between CTCs/c-Kit expression of CTCs and the prognosis of EC patients was analyzed in EC.
A total of 43 EC patients with R0 resection were recruited for this study. The CanPatrol method was used to detect the CTC number in the peripheral blood of patients before and after operations, and the epithelial/interstitial type was classified. Multiple RNA in situ hybridization (RNA-ISH) was used to observethe c-Kit expression of CTCs. Post-operation follow-up occurred over 3 years. Logistic regression or the Cox proportional risk regression model was applied to analyze the relationship between CTC number, CTCs and disease characteristics, pathological stages and prognosis of patients with EC, and changes in CTCs before and after operations. c-Kit expression in different CTCs and the relationship between c-Kit expression and prognosis were also studied.
The detection rate of CTCswas 81% (35/43). The detection rates of epithelial-, mixed- and stromal-type CTCs were 53%, 63%, and 33%, respectively. The 3-year overall survival rate was 67%. A CTC level of >2 indicated an increased risk of recurrence, metastasis, and death (P=0.018, 0.002, respectively). Following the operations, the total number of CTCs decreased in 29 cases. Of these, 6 cases were unchanged, and 8 cases demonstrated elevated CTCs. There was a significant difference in the positive rate of mixed-type CTCs before and after the operations. The rate of c-Kit expression in CTCs of EC patients was 46% pre-operation. No statistically significant correlations were found between c-Kit expression and postoperative recurrence/metastasis/survival of EC patients.
Preoperative CTC numbers, especially interstitial CTCs, were used as an auxiliary index in the prognosis of EC patients. The mRNA expression of c-Kit was detected in CTCs preoperatively in patients with EC, but no significant correlation between the c-Kit expression and the prognosis of EC patients was found.
食管癌(EC)是全球最常见的恶性肿瘤之一,发病率和死亡率都很高。循环肿瘤细胞(CTC)检测已成为食管癌临床研究中的一种新方法。在本研究中,分析了食管癌患者的CTC数量/ CTC的c-Kit表达与预后之间的关系。
本研究共纳入43例行R0切除的食管癌患者。采用CanPatrol方法检测患者术前和术后外周血中的CTC数量,并对上皮/间质类型进行分类。采用多重RNA原位杂交(RNA-ISH)观察CTC的c-Kit表达。术后随访3年。应用逻辑回归或Cox比例风险回归模型分析食管癌患者的CTC数量、CTC与疾病特征、病理分期及预后之间的关系,以及手术前后CTC的变化。还研究了不同CTC中c-Kit的表达以及c-Kit表达与预后的关系。
CTC的检出率为81%(35/43)。上皮型、混合型和间质型CTC的检出率分别为53%、63%和33%。3年总生存率为67%。CTC水平>2表明复发、转移和死亡风险增加(P分别为0.018、0.002)。手术后,29例患者的CTC总数减少。其中,6例无变化,8例CTC升高。手术前后混合型CTC的阳性率有显著差异。食管癌患者术前CTC中c-Kit表达率为46%。未发现c-Kit表达与食管癌患者术后复发/转移/生存之间存在统计学显著相关性。
术前CTC数量,尤其是间质CTC,可作为食管癌患者预后的辅助指标。术前在食管癌患者的CTC中检测到c-Kit的mRNA表达,但未发现c-Kit表达与食管癌患者预后之间存在显著相关性。